首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Is It a New Approach for Treating Senile Hypertension with Kidney-Tonifying Chinese Herbal Formula? A Systematic Review of Randomized Controlled Trials
【24h】

Is It a New Approach for Treating Senile Hypertension with Kidney-Tonifying Chinese Herbal Formula? A Systematic Review of Randomized Controlled Trials

机译:它是一种补肾补肾中药治疗老年高血压的新方法吗?随机对照试验的系统评价

获取原文
       

摘要

Objective. To assess the effect of kidney-tonifying (KT) Chinese herbal formula for senile hypertension (SH).Methods. A total of five databases (CENTRAL, Pubmed, CBM, CNKI, and VIP) were searched for published and unpublished randomized controlled trials (RCTs) up to November 30th, 2013. We included RCTs that confoundedly addressed the effect of KT formula in the treatment of SH.Results. Six studies involving 527 people were included. There was no evidence that KT formula alone had superior effects to antihypertensive drugs in systolic blood pressure (MD: −3.70 (−11.47, 4.07);P=0.35) and diastolic blood pressure (MD: −3.00 (−7.26, −1.26);P=0.17). However, there was evidence that KT formula combined with antihypertensive drugs was a better treatment option than antihypertensive drugs alone in systolic blood pressure (WMD: −8.69 (−12.35, −5.02);P<0.00001) but no significant difference in diastolic blood pressure (WMD: −1.32 (−7.93, −5.30);P=0.7). In addition, after several weeks of treatment, the level of blood lipid, endothelin, blood urea nitrogen, and creatinine decreased significantly (P<0.05).Conclusion. Compared with antihypertensive drugs alone, KT formula combined with antihypertensive drugs may provide more benefits for patients with SH. The large-scale high-quality trials are warranted in future.
机译:目的。评估补肾(KT)中草药配方对老年高血压(SH)的作用。截至2013年11月30日,总共搜索了五个数据库(CENTRAL,Pubmed,CBM,CNKI和VIP)以查找已发表和未发表的随机对照试验(RCT)。我们纳入的RCT混淆了治疗中KT配方的疗效SH.Results。包括527人的六项研究被纳入。没有证据表明单独的KT配方对收缩压(MD:-3.70(−11.47,4.07); P = 0.35)和舒张压(MD:−3.00(−7.26,-1.26)优于抗高血压药; P = 0.17)。但是,有证据表明,在收缩压方面,KT配方联合降压药比单独使用降压药更好的治疗选择(WMD:−8.69(−12.35,-5.02); P <0.00001),但舒张压无明显差异(WMD:-1.32(-7.93,-5.30); P = 0.7)。此外,经过数周的治疗,血脂,内皮素,血尿素氮和肌酐水平显着下降(P <0.05)。与单独使用降压药相比,KT配方结合降压药可能为SH患者提供更多益处。将来有必要进行大规模的高质量试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号